Levetiracetam Tablet, Film Coated
Product Images NDC 50090-6378

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50090-6378). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 01)

A formula illustration showing the calculation for total daily dose in milliliters per day, expressed as daily dose (mg/kg/day) multiplied by patient weight (kg), divided by 100 mg/mL concentration.*

FDA Label Image

Figure 2 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 02)

A text panel showing formulas for calculating creatinine clearance (CLcr) including adjustment for body surface area (BSA). It provides the calculation steps using age, weight, serum creatinine, and a factor for female patients, followed by adjustment for BSA in mL/min per 1.73 m².*

FDA Label Image

Structure (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 03)

Chemical structure of levetiracetam, showing its molecular arrangement including a pyrrolidone ring and side chains represented by standard chemical notation.*

FDA Label Image

Figure 4 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 04)

A bar chart comparing the percentage of patients across three groups: Placebo (95 patients), Levetiracetam 1000 mg/day (97 patients), and Levetiracetam 3000 mg/day (101 patients). The y-axis shows the percentage of patients from 0% to 45%, with Placebo at 7.4%, Levetiracetam 1000 mg/day at 37.1%, and Levetiracetam 3000 mg/day at 39.6%. Asterisks mark the bars for Levetiracetam groups.*

FDA Label Image

Figure 5 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 05)

A bar chart showing the percentage of patients across three groups: Placebo (111 patients) with 6.3%, Levetiracetam 1000 mg/day (106 patients) with 20.8%, and Levetiracetam 2000 mg/day with 35.2%. The y-axis represents the percentage of patients from 0% to 45%.*

FDA Label Image

Figure 6 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 06)

A bar chart comparing the percentage of patients between two groups: a placebo group with 104 patients showing 14.4%, and a Levetiracetam 3000 mg/day group with 180 patients showing 39.4%. The y-axis represents the percentage of patients from 0% to 45%.*

FDA Label Image

Figure 7 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 07)

A bar chart comparing the percentage of patients between placebo and Levetiracetam groups. The y-axis represents % of patients, with placebo at 19.6% and Levetiracetam at 44.6%, indicating a higher percentage in the Levetiracetam group. Sample sizes are 97 for placebo and 101 for Levetiracetam.*

FDA Label Image

Figure 8 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 08)

A bar graph comparing the percentage of patients between two groups: Placebo (N=51) and Levetiracetam (N=58). The y-axis represents the percentage of patients, ranging from 0% to 45%. The Placebo group shows 19.6%, while the Levetiracetam group shows 43.1%.*

FDA Label Image

Figure 9 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 09)

A bar chart comparing the percentage of patients between two groups: Placebo (N=84) and Levetiracetam (N=79). The chart shows approximately 45.2% of patients in the Placebo group and 72.2% in the Levetiracetam group, with the Levetiracetam bar marked by an asterisk indicating statistical significance.*

FDA Label Image

Label Image (Lbl500906378)

Levetiracetam 1000 mg film-coated tablets label from A-S Medication Solutions. The label shows the active ingredient Levetiracetam USP 1000 mg per tablet, indicates storage at 77 degrees Fahrenheit, and states the package contains 30 tablets. It includes the product NDC 50090-6378-0 and a QR code with a barcode below.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.